Group Successfully Improves Life of Youngest Ever Stroke Patient to be Treated with Umbilical Cord Stem Cells

Shenzhen, People’s Republic of China –- March 2, 2006 — Shenzhen Beike Biotechnology Co., Ltd has announced the successful treatment with umbilical cord stem cells of the youngest ever stroke…

Beike Biotechnology Opens First Chinese Rehabilitation Center in Romania

New Center Integrates Traditional Chinese, Romanian and Western Therapies CAMPINA and PRAHOVA, Romania, July 20 /PRNewswire-Asia/ — Beike Biotechnology Co. Ltd. (https://www.beikebiotech.com/index.php ), one of the world’s leading biotechnology companies…

First Cerebral Palsy treatment using two types of stem cells

First Cerebral Palsy treatment using two types of stem cells

Just in time for Cerebral Palsy (CP) awareness month, Europe’s ESPERITE group is championing the first clinical trial to utilize two types of stem cells for the treatment of Cerebral…

Stem Cell Leader Beike Biotech and China’s Tsinghua University Receive USD $4 Million for Stem Cell

Patients suffering from a range of debilitating illnesses, such as spinal cord injury, cerebral palsy, optic nerve hypoplasia, multiple sclerosis and ataxia stand to benefit from a new laboratory, established…

Beike Biotechnology, Jiangsu University and Nanjing Drum Tower Hospital Receive $1.8 Million for Human Mesenchymal Stem Cell R&D and Clinical Trials

TAIZHOU, Jiangsu, China, January 6 – The Jiangsu Government’s Science and Technology Department has announced a $1.8 million grant – the Jiangsu Technological Achievements Transformational Grant – to support the…

Beike CSO Speaks at IPA Diabetic Foot Care Conference, India

NEW DELHI, India, Dec. 3 /PRNewswire-Asia/ — Dr. Susan Jiang, M.D., Ph.D., Chief Science Officer at Shenzhen Beike Biotechnology Co. Ltd. (https://www.beikebiotech.com ), spoke at a conference on High-Risk Diabetic…


1 2 8 9